
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.
All lifecos will benefit in a rising interest rate environment. Recent earnings reported were not that fantastic and thinks this has to do with the historic volatility of their earnings. Doesn’t think the market is giving the lifecos the benefit of the doubt, but there is no question that this is a good way to play a rising rate environment.
Metrlife (MET-N) or Manulife (MFC-T). Which has a better upside? All things being equal, and if she liked both of them equally, she would prefer the Canadian stock because of the currency. They have good business in Asia which, longer-term, is going to be a good growth area. Lower interest rates are going to be a headwind, but that is a non-core issue. Valuation is not onerous and it provides an attractive yield.
If interest rates rise, this will work. If they don’t, it will stay in the same range. Excellent company. The company has been de-risked to such an extent that the increase in equities hasn’t really driven the company to a higher level. Because of this, he prefers Sun Life (SLF-T). If you have a longer-term outlook, this is fine.
He has an issue with the low interest rate environment and insurance companies. But they have brought their leverage down and that has helped them. They would like to do acquisitions, but the big ones are few and far between. They can grow their ROE, but you need to still see less leverage on their balance sheet. He prefers SLF-T where they have the asset management business.
This is under a lot of pressure. The interest rate scenario is obviously not positive for insurance companies. The CEO wants to get the company up to $4 billion in core revenue, and right now they are at about $3 billion. They are going to need a lot of things to go right in order to get the last billion dollars squeezed out. He is right on the edge about being nervous in owning this name. 50% of their revenues are coming in from abroad including the US and Asia. They need a better market and they need rates to go up for them to do much better from here.
Canadian banks or Manulife (MFC-T)? Until recently, he thought lifecos showed relatively better valuation than banks. The environment has got to the point now where flight to safety might be tilting a little bit more towards banks. Management has done a superb job since they were in trouble previously and had to cut their dividend. Have changed their product mix so that it is a lot less risky and less exposed to equity markets. Have really built up the wealth side of their business giving them good fees. Expanded in the US through John Hancock and are expanding into Asia quite a bit. A very good long-term hold.